Role of AT1 receptor-mediated salt retention in angiotensin II-dependent hypertension

被引:44
作者
Crowley, Steven D. [1 ,2 ]
Zhang, Jiandong [1 ,2 ]
Herrera, Maria [1 ,2 ]
Griffiths, Robert [1 ,2 ]
Ruiz, Phillip [3 ]
Coffman, Thomas M. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Div Nephrol, Durham, NC 27710 USA
[2] Durham Vet Affairs Med Ctr, Durham, NC USA
[3] Univ Miami, Dept Pathol, Miami, FL USA
基金
美国国家卫生研究院;
关键词
kidney diseases; REMNANT KIDNEY MODEL; BLOOD-PRESSURE; DISTINCT ROLES; RENAL DAMAGE; ALDOSTERONE; INJURY; RENIN; BLOCKADE; LOSARTAN; THERAPY;
D O I
10.1152/ajprenal.00305.2011
中图分类号
Q4 [生理学];
学科分类号
071003 [生理学];
摘要
Crowley SD, Zhang J, Herrera M, Griffiths R, Ruiz P, Coffman TM. Role of AT(1) receptor-mediated salt retention in angiotensin II-dependent hypertension. Am J Physiol Renal Physiol 301: F1124-F1130, 2011. First published August 17, 2011; doi:10.1152/ajprenal.00305.2011.-Activation of type 1 angiotensin II (AT(1)) receptors in the kidney promotes blood pressure elevation and target organ damage, but whether renal AT(1) receptors influence the level of hypertension by stimulating sodium retention or by raising systemic vascular resistance has not been established. In the current studies, we used a kidney cross-transplantation strategy to determine whether increased sodium reabsorption by AT(1) receptors in the kidney mediates the chronic hypertensive response to angiotensin II. We found this to be true. In addition, we also identified a second, nontrivial component of blood pressure elevation induced by activation of renal AT(1) receptors that is sodium-independent. As the kidney has the capacity to limit the transmission of elevated systemic blood pressure into the renal microcirculation, prior studies struggled to clearly discriminate the relative contributions of blood pressure elevation vs. activation of AT(1) receptors to hypertensive kidney injury. In our model, we found that rapid surges in blood pressure, which may overcome the kidney's capacity to prevent perturbations in renal hemodynamics, correlate closely with kidney damage in hypertension. Moreover, maximal kidney injury in hypertension may require activation of a pool of nonrenal, systemic AT(1) receptors. These studies provide insight into precise mechanisms through which AT(1) receptor blockade influences the progression of hypertensive kidney disease.
引用
收藏
页码:F1124 / F1130
页数:7
相关论文
共 27 条
[1]
Nongenomic vascular action of aldosterone in the glomerular microcirculation [J].
Arima, S ;
Kohagura, K ;
Xu, HL ;
Sugawara, A ;
Abe, T ;
Satoh, F ;
Takeuchi, K ;
Ito, S .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (09) :2255-2263
[2]
Pathophysiology of hypertensive renal damage - Implications for therapy [J].
Bidani, AK ;
Griffin, KA .
HYPERTENSION, 2004, 44 (05) :595-601
[3]
CONTINUOUS TELEMETRIC BLOOD-PRESSURE MONITORING AND GLOMERULAR INJURY IN THE RAT REMNANT KIDNEY MODEL [J].
BIDANI, AK ;
GRIFFIN, KA ;
PICKEN, M ;
LANSKY, DM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (03) :F391-F398
[4]
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[5]
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo [J].
Brown, NJ ;
Nakamura, S ;
Ma, LJ ;
Nakamura, I ;
Donnert, E ;
Freeman, M ;
Vaughan, DE ;
Fogo, AB .
KIDNEY INTERNATIONAL, 2000, 58 (03) :1219-1227
[6]
ESSENTIAL HYPERTENSION - RENIN AND ALDOSTERONE, HEART ATTACK AND STROKE [J].
BRUNNER, HR ;
BUHLER, FR ;
BARD, RH ;
BAER, L ;
GOODWIN, FT ;
NEWTON, MA ;
KRAKOFF, LR ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (09) :441-+
[7]
Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker [J].
Chrysostomou, Anastasia ;
Pedagogos, Eugenia ;
MacGregor, Lachlan ;
Becker, Gavin J. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (02) :256-262
[8]
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system [J].
Crowley, SD ;
Gurley, SB ;
Oliverio, MI ;
Pazmino, AK ;
Griffiths, R ;
Flannery, PJ ;
Spurney, RF ;
Kim, HS ;
Smithies, O ;
Le, TH ;
Coffman, TM .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04) :1092-1099
[9]
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney [J].
Crowley, Steven D. ;
Gurley, Susan B. ;
Herrera, Maria J. ;
Ruiz, Phillip ;
Griffiths, Robert ;
Kumar, Anil P. ;
Kim, Hyung-Suk ;
Smithies, Oliver ;
Le, Thu H. ;
Coffman, Thomas M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (47) :17985-17990
[10]
A Role for Angiotensin II Type 1 Receptors on Bone Marrow-Derived Cells in the Pathogenesis of Angiotensin II-Dependent Hypertension [J].
Crowley, Steven D. ;
Song, Young-Soo ;
Sprung, Gregory ;
Griffiths, Robert ;
Sparks, Matthew ;
Yan, Ming ;
Burchette, James L. ;
Howell, David N. ;
Lin, Eugene E. ;
Okeiyi, Benson ;
Stegbauer, Johannes ;
Yang, Yanqiang ;
Tharaux, Pierre-Louis ;
Ruiz, Phillip .
HYPERTENSION, 2010, 55 (01) :99-U180